CORTICO BIOSIM
Dead / Abandoned — Abandoned — failure to respond (as of 26 Jul 2023)
What this means for you
This application is over — abandoned 23 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90887861
- Mark type
- Stylized text
- Filed
- 17 Aug 2021
- Abandoned
- 23 May 2023
- Attorney of record
- Joseph I. Hirsch
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, corticotropin compositions for use in diagnostic testing and for treatment of disorders such as endocrine disorders, nervous system diseases, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, opthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, tuberculous meningitis and trichinosis
Owner
- Cortico BioSim LLC, Albuquerque, NM, US
Prosecution history
- 26 Jul 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 26 Jul 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 26 Jul 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 21 Feb 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 21 Feb 2023 — FINAL REFUSAL E-MAILED
- 21 Feb 2023 — FINAL REFUSAL WRITTEN
- 29 Dec 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Dec 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Dec 2022 — ASSIGNED TO LIE
- 02 Nov 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 May 2022 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 18 May 2022 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 18 May 2022 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
- 18 May 2022 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
- 18 May 2022 — ASSIGNED TO EXAMINER